{"id":"W4380084938","doi":"10.1002/hon.3163_95","title":"GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (<i>R</i>/<i>R</i>) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Kite Pharma; F. Hoffmann-La Roche; Genentech; Celgene; Gilead Sciences; Pharmacyclics; Sanofi; Pfizer; Bristol-Myers Squibb","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005888859,0.0004231723,0.001469336,0.0004204212,0.0001917593,0.00002709053,0.0002298418,0.0004237392,0.001305497],"category_scores_gemma":[0.0001905736,0.0002909395,0.0001551615,0.0009615636,0.0002294796,0.0001087136,0.0002652948,0.0004959323,0.00008759383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002780245,"about_ca_system_score_gemma":0.0002324223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001736561,"about_ca_topic_score_gemma":0.0003299672,"domain_scores_codex":[0.9962661,0.0005772116,0.00067179,0.0009484934,0.0006576342,0.0008787843],"domain_scores_gemma":[0.9978475,0.0008779567,0.0001916583,0.0005730202,0.0001400639,0.0003698171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05571701,0.06990155,0.8113313,0.00007525838,0.0007295393,0.005829053,0.003766075,0.000001544212,0.01106109,0.00004987068,0.002731335,0.03880632],"study_design_scores_gemma":[0.3111354,0.06139693,0.6050625,0.00008202655,0.0002806676,0.00008037707,0.002883125,0.0003562822,0.001197702,0.0003227667,0.01655243,0.0006497646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954123,0.0004706431,0.00002456953,0.0003555417,0.0001537123,0.001772247,0.00005874844,0.0002122289,0.001539955],"genre_scores_gemma":[0.9967512,0.0001984291,0.0002694669,0.0005696681,0.00006749115,0.0002459032,0.0001848056,0.00005964803,0.001653385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2554184,"threshold_uncertainty_score":0.9999543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04688872729011315,"score_gpt":0.3771005735176207,"score_spread":0.3302118462275075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}